SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000921895-23-002543
Filing Date
2023-11-09
Accepted
2023-11-09 16:43:58
Documents
5

Document Format Files

Seq Description Document Type Size
1 THE SCHEDULE 13D sc13d12208003_11092023.htm SC 13D 119762
2 LETTER TO THE BOARD, DATED NOVEMBER 9, 2023 ex991to13d12208003_11092023.htm EX-99.1 13700
3 JOINT FILING AGREEMENT ex992to13d12208003_11092023.htm EX-99.2 4248
4 GRAPHIC image_001.jpg GRAPHIC 7577
5 GRAPHIC image_002.jpg GRAPHIC 15719
  Complete submission text file 0000921895-23-002543.txt   171569
Mailing Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6
Business Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Subject) CIK: 0001408443 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-91001 | Film No.: 231393350
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1500 BROADWAY SUITE 704 NEW YORK NY 10036
Business Address 1500 BROADWAY SUITE 704 NEW YORK NY 10036 2123191778
Alta Fundamental Advisers LLC (Filed by) CIK: 0001641604 (see all company filings)

IRS No.: 461788509 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D